Streptokinase-streptodornase was a combination medication that is no longer commonly used. Here's a breakdown of its components and why it's not widely used today:
Components:
- Streptokinase: As described previously, it's a thrombolytic drug that dissolves blood clots [1].
- Streptodornase: This is an enzyme with a different function. It breaks down DNA in dead or pus-forming cells [2].
Intended Use:
- The combination of these two enzymes aimed to treat infections with a focus on dissolving blood clots and removing dead tissue or pus that might be hindering healing [2].
Reasons for Decline:
- Streptokinase limitations: The use of streptokinase as a clot buster has significantly decreased due to the availability of safer and more clot-specific thrombolytic drugs like alteplase (tPA) with a lower risk of bleeding [3, 4].
- Limited benefit of streptodornase: The additional benefit of streptodornase in dissolving pus is not well established, and other treatments might be more effective for managing infections [5].
- Safety concerns: The combination of these enzymes carried a potential for increased bleeding risk, especially with streptokinase's action.
Alternatives:
- More targeted clot-dissolving medications and various antibiotics are now the preferred options for treating blood clots and infections, respectively.